Pulse.

a daily field guide to health research that matters

◆ Console

‹ Mon · 26 Oct 2026
Standard addition

Timing of cranial radiotherapy in HER2-positive breast Cancer brain metastases treated with Pyrotinib: a multicentre real-world cohort study.

Focal radiation to the brain improves survival in HER2-positive breast cancer patients with brain involvement, with manageable side effects.

We evaluated survival across treatment sequences within a real-world cohort. Focal cranial RT was independently associated with longer survival, and toxicity was manageable.

What the study was

Study design
Retrospective cohort study
Population
We evaluated survival across treatment sequences within a real-world cohort.
Sample size
101
Category
Treatment Innovation
Maturity
Exploratory
Journal
Clin Transl Radiat Oncol

Why it surfaced

Retrospective cohort study with a PubMed abstract reviewed; the 7/10 score reflects conservative novelty, relevance, design-quality, and population/unmet-need assessment.

A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.